Masimo (NASDAQ:MASI) Shares Cross Above Two Hundred Day Moving Average – Here’s What Happened

Masimo Co. (NASDAQ:MASI)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $138.22 and traded as high as $169.66. Masimo shares last traded at $168.80, with a volume of 634,326 shares trading hands.

Analysts Set New Price Targets

A number of analysts have recently issued reports on MASI shares. Wells Fargo & Company raised their price target on shares of Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Raymond James lifted their target price on Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research report on Friday, December 27th. Stifel Nicolaus reiterated a “buy” rating and set a $190.00 price target (up from $170.00) on shares of Masimo in a report on Friday, November 22nd. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Wednesday, November 6th. Finally, BTIG Research upped their target price on shares of Masimo from $166.00 to $170.00 and gave the company a “buy” rating in a research report on Monday, October 14th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $179.67.

Masimo Trading Up 2.0 %

The stock has a market cap of $9.04 billion, a price-to-earnings ratio of 116.41 and a beta of 1.01. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. The company has a 50 day moving average of $167.18 and a 200-day moving average of $138.22.

Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, beating the consensus estimate of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The business had revenue of $504.60 million during the quarter, compared to analyst estimates of $502.87 million. During the same quarter last year, the firm posted $0.63 earnings per share. The business’s revenue for the quarter was up 5.4% compared to the same quarter last year. On average, research analysts anticipate that Masimo Co. will post 4.03 earnings per share for the current year.

Institutional Trading of Masimo

Hedge funds have recently modified their holdings of the stock. NBC Securities Inc. increased its holdings in Masimo by 47.1% during the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 73 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in shares of Masimo by 133.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 200 shares during the period. GAMMA Investing LLC raised its holdings in Masimo by 136.5% in the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider’s stock valued at $77,000 after acquiring an additional 269 shares in the last quarter. HHM Wealth Advisors LLC grew its holdings in Masimo by 25.0% during the 2nd quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider’s stock worth $79,000 after acquiring an additional 125 shares in the last quarter. Finally, Headlands Technologies LLC purchased a new stake in shares of Masimo in the 2nd quarter valued at approximately $109,000. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.